Paper156196
Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency.
Aoki N and 5 others. J Clin Invest, 1979. Cited by 192 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency. Papers, record 156196. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/156196
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibrinolysin | Major topic |
| Hemorrhagic Disorders | Major topic |
| Adult | |
| Blood Coagulation Tests | |
| Consanguinity | |
| Fibrinolysis | |
| Humans | |
| Male | |
| Pedigree |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 68,962 | The behavior of alpha2-plasmin inhibitor in fibrinolytic states. | J Clin Invest | 1977 | https://conductscience.org/library/papers/68962 | PubMed |
| 2 | 70,081 | Inhibition of plasminogen binding to fibrin by alpha2-plasmin inhibitor. | Thromb Res | 1977 | https://conductscience.org/library/papers/70081 | PubMed |
| 3 | 70,499 | Plasmin inhibitor interactions. The effectiveness of alpha2-plasmin inhibitor in the presence of alpha2-macroglobulin. | J Exp Med | 1977 | https://conductscience.org/library/papers/70499 | PubMed |
| 4 | 73,215 | Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate. | Scand J Clin Lab Invest | 1977 | https://conductscience.org/library/papers/73215 | PubMed |
| 5 | 76,519 | The alpha2-plasmin inhibitor levels in liver diseases. | Clin Chim Acta | 1978 | https://conductscience.org/library/papers/76519 | PubMed |
| 6 | 77,050 | Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin. | Thromb Haemost | 1978 | https://conductscience.org/library/papers/77050 | PubMed |
| 7 | 124,594 | Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation. Influence of omega-aminocarboxylic acids. | Biochim Biophys Acta | 1975 | https://conductscience.org/library/papers/124594 | PubMed |
| 8 | 126,095 | The resistance of fibrinogen and soluble fibrin monomer in blood to degradation by a potent plasminogen activator derived from cadaver limbs. | Blood | 1975 | https://conductscience.org/library/papers/126095 | PubMed |
| 9 | 131,386 | Properties of a partially purified preparation of a circulating plasminogen activator. | Thromb Res | 1976 | https://conductscience.org/library/papers/131386 | PubMed |
| 10 | 134,998 | Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis. | J Biol Chem | 1976 | https://conductscience.org/library/papers/134998 | PubMed |
| 11 | 136,345 | Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma. | Eur J Biochem | 1976 | https://conductscience.org/library/papers/136345 | PubMed |
| 12 | 137,718 | The primary inhibitor of plasmin in human plasma. | Biochem J | 1976 | https://conductscience.org/library/papers/137718 | PubMed |
| 13 | 144,728 | Inhibition of proteases in coagulation, kinin-forming and complement systems by alpha2-plasmin inhibitor. | J Biochem | 1977 | https://conductscience.org/library/papers/144728 | PubMed |
| 14 | 145,863 | Protease inhibitors and human plasmin: interaction in a whole plasma system. | Biochem Biophys Res Commun | 1977 | https://conductscience.org/library/papers/145863 | PubMed |
| 15 | 146,272 | Serine protease specificity for peptide chromogenic substrates. | Thromb Haemost | 1977 | https://conductscience.org/library/papers/146272 | PubMed |
| 16 | 151,345 | Assay of alpha2-plasmin inhibitor activity by means of a plasmin specific tripeptide substrate. | Thromb Res | 1978 | https://conductscience.org/library/papers/151345 | PubMed |
| 17 | 234,499 | Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor. | J Lab Clin Med | 1975 | https://conductscience.org/library/papers/234499 | PubMed |
| 18 | 291,382 | Distribution of cold-insoluble globulin in plasma and tissues. | Ann N Y Acad Sci | 1978 | https://conductscience.org/library/papers/291382 | PubMed |
| 19 | 659,588 | Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis. | J Clin Invest | 1978 | https://conductscience.org/library/papers/659588 | PubMed |
| 20 | 884,316 | Plasma thromboplastin antecedent (PTA, factor XI): a specific and sensitive radioimmunoassay. | Blood | 1977 | https://conductscience.org/library/papers/884316 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 192 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,867,572 | Effect of Alpha2-Plasmin Inhibitor C-Terminal Heterogeneity on Clot Lysis and Clot Structure. | Biomolecules | 2025 | https://conductscience.org/library/papers/40867572 | PubMed |
| 39,628,652 | Enhanced thrombin and plasmin generation profiles in alpha-2-antiplasmin-deficient patients: Data from the Rare Bleeding disorders in the Netherlands study. | Res Pract Thromb Haemost | 2024 | https://conductscience.org/library/papers/39628652 | PubMed |
| 36,452,200 | Plasmin Inhibitor in Health and Diabetes: Role of the Protein as a Therapeutic Target. | TH Open | 2022 | https://conductscience.org/library/papers/36452200 | PubMed |
| 33,426,005 | Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease. | Front Cardiovasc Med | 2020 | https://conductscience.org/library/papers/33426005 | PubMed |
| 31,136,528 | Variability in international normalized ratio and activated partial thromboplastin time after injury are not explained by coagulation factor deficits. | J Trauma Acute Care Surg | 2019 | https://conductscience.org/library/papers/31136528 | PubMed |
| 28,622,377 | Hemostatic function to regulate perioperative bleeding in patients undergoing spinal surgery: A prospective observational study. | PLoS One | 2017 | https://conductscience.org/library/papers/28622377 | PubMed |
| 28,251,495 | New clotting disorders that cast new light on blood coagulation and may play a role in clinical practice. | J Thromb Thrombolysis | 2017 | https://conductscience.org/library/papers/28251495 | PubMed |
| 27,477,022 | Bleeding related to disturbed fibrinolysis. | Br J Haematol | 2016 | https://conductscience.org/library/papers/27477022 | PubMed |
| 21,765,837 | Alpha II Antiplasmin Deficiency Complicating Pregnancy: A Case Report. | Obstet Gynecol Int | 2011 | https://conductscience.org/library/papers/21765837 | PubMed |
| 20,687,529 | Noncovalent interaction of alpha(2)-antiplasmin with fibrin(ogen): localization of alpha(2)-antiplasmin-binding sites. | Biochemistry | 2010 | https://conductscience.org/library/papers/20687529 | PubMed |
| 20,039,075 | Lessons from the aprotinin saga: current perspective on antifibrinolytic therapy in cardiac surgery. | J Anesth | 2010 | https://conductscience.org/library/papers/20039075 | PubMed |
| 18,564,219 | Evidence that alpha2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation. | J Thromb Haemost | 2008 | https://conductscience.org/library/papers/18564219 | PubMed |
| 9,892,694 | The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/9892694 | PubMed |
| 7,199,538 | Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. | J Clin Invest | 1982 | https://conductscience.org/library/papers/7199538 | PubMed |
| 7,044,545 | Coagulative interventions during angiography. | Cardiovasc Intervent Radiol | 1982 | https://conductscience.org/library/papers/7044545 | PubMed |
| 6,448,868 | Biological role of fibrinolysis. | J Clin Pathol Suppl (R Coll Pathol) | 1980 | https://conductscience.org/library/papers/6448868 | PubMed |
| 6,444,305 | Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor. | J Clin Invest | 1980 | https://conductscience.org/library/papers/6444305 | PubMed |
| 6,291,058 | Synthesis and secretion of alpha 2-plasmin inhibitor by established human liver cell lines. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6291058 | PubMed |
| 6,166,634 | Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay. | J Clin Invest | 1981 | https://conductscience.org/library/papers/6166634 | PubMed |
| 3,315,578 | Physiological balance of haemostasis and bleeding. | Drugs | 1987 | https://conductscience.org/library/papers/3315578 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| A2M | 2 | PubTator's text mining | https://conductscience.org/library/genes/2 | NCBI Gene |
| PLG | 5,340 | PubTator's text mining | https://conductscience.org/library/genes/5340 | NCBI Gene |
| SERPINA1 | 5,265 | PubTator's text mining | https://conductscience.org/library/genes/5265 | NCBI Gene |
| SERPINC1 | 462 | PubTator's text mining | https://conductscience.org/library/genes/462 | NCBI Gene |
| SERPINF2 | 5,345 | PubTator's text mining | https://conductscience.org/library/genes/5345 | NCBI Gene |
| SERPING1 | 710 | PubTator's text mining | https://conductscience.org/library/genes/710 | NCBI Gene |
| WDTC1 | 23,038 | PubTator's text mining | https://conductscience.org/library/genes/23038 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/156196
GET https://conductscience.org/api/papers/v1/156196/references?page=2